Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Finasteride helps hair growth but may cause sexual side effects and depression.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Certain gene variations increase male hair loss risk, influenced by hormone levels.